Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73) - Image 1

£149.64

Springer Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

Name: Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)
Brand: Springer
Price: 148.74 GBP
Availability: InStock

Oncology

Price History & Forecast

Last 80 days • 80 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 80 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £149 (79 days, 98.8%)

Price range: £149 - £150

Price levels: 2 different prices over 80 days

Description

Over the last 50 years, drug development and clinical trials have resulted in successful complete responses in diseases such as childhood leukemia, testicular cancer and Hodgkin's disease. We are still, however, confronted with over 500,000 cancer-related deaths per year. Clearly, the phenomenon of drug resistance is largely responsible for these failures and continues to be an area of active investigation. Since the last volume in this series, we have learned that the energy-dependent drug efflux protein, p-glycoprotein, encoded by the MDR 1 gene, is a member of a family of structurally related transport polypeptides, thus allowing us to explore the relationship between structure and function. In addition to ongoing well designed clinical trials aimed at reversing MDR mediated drug resistance, the first gene therapy studies with the MDR 1 gene retrovirally transduced into human bone marrow cells are about to be initiated. Although MDR is currently the most understood mechanism of drug resistance, we are uncovering increasing knowledge of alternative molecular and biochemical mechanisms of drug resistance to antimetabolites, cisplatin and alkylating agents and developing new strategies for circumventing such resistance. It is clear that drug resistance is complex, and many mechanisms exist by which cancer cells may overcome the cytotoxicity of our known chemotherapeutic agents. As our understanding of each of these mechanisms expands, well designed models will be necessary to test laboratory hypotheses and determine their relationship to drug resistance in humans. It is this integration of basic science and clinical investigation that will both advance our scientific knowledge and result in the improvement of cancer therapy.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 146136129X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Publication Date: 11 October 2012
Listed Since: 03 March 2013

Barcode

No barcode data available

Springer Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches: v. 1

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Drug Resistance in Cancer Cells

Cytotoxic Drug Resistance Mechanisms: 28 (Methods in Molecular Medicine, 28)

Progress in Cancer Drug Resistance Research

Drug Resistant Neoplasms (Cancer Etiology Diagnosis and Treatment Series)

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects

Multiple Drug Resistance in Cancer 2: Molecular, Cellular and Clinical Aspects

Springer - Molecular Mechanisms of Tumor Cell Resistance

Springer - Therapeutic Resistance to Anti-hormonal Drugs Book

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Chemistry and Pharmacology of Anticancer Drugs

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)